Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Rakhmad Hidayat, Al Rasyid, Salim Harris, Alida Harahap, Herqutanto, Melva Louisa, Erlin Listiyaningsih, Aldy Safruddin Rambe & Tonny Loho. (2023) Correlation P2Y12 Genetic Polymorphism As Risk Factor of Clopidogrel Resistance in Indonesian Stroke Patients. Vascular Health and Risk Management 19, pages 53-61.
Read now
Read now
Articles from other publishers (65)
Kaili Zhang, Yongle Wang, Tingting Liu & Xiaoyuan Niu. (2023) Comparison of Aspirin and P2Y12 Inhibitors for Secondary Prevention of
Ischaemic Stroke: A Systematic Review and Meta-analysis. Current Reviews in Clinical and Experimental Pharmacology 18:3, pages 270-283.
Crossref
Crossref
Christopher M. McKinnie & Mark B. Effron. (2023) More Potent Antiplatelet Therapy in Acute Coronary Syndrome Patients With Prior Stroke: Proceed With Caution?. Mayo Clinic Proceedings 98:11, pages 1590-1592.
Crossref
Crossref
Ali Alshahrani & Sean O’Nunain. (2023) Is triple antithrombotic therapy a safe option in patients with AF who receive drug-eluting stents?: a review article. The Egyptian Heart Journal 75:1.
Crossref
Crossref
Rakhmad Hidayat, Al Rasyid, Salim Harris, Alida R. Harahap, Herqutanto, Melva Louisa, Erlin Listiyaningsih, Aldy Safruddin Rambe & Tonny Loho. (2023) The stent thrombosis in Belgium (STIB) scoring system reliability in Indonesia patients and the modified STIB scoring (M-STIB). The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 59:1.
Crossref
Crossref
Kaili Zhang, Tingting Liu, Haimei Fan, Yongle Wang, Yanan Li, Juan Li, Yali Li, Yaqin Yu, Junhui Wang, Lixi Xue, Wenxian Du, Wenhua Niu, Yuping Yan, Xiaolei Gao, Gaimei Li, Qingping Liu, Yuting Liu, Yanhong Fan, Jing Ren, Xinyi Li, Xuemei Wu & Xiaoyuan Niu. (2023) Dual Versus Mono Antiplatelet Therapy in Patients with Acute Mild-to-Moderate Stroke: A Multicentre Perspective Cohort Study. Cardiovascular Drugs and Therapy.
Crossref
Crossref
Astuti Giantini, Ina S. Timan, Rahajuningsih Dharma, Renan Sukmawan, Rianto Setiabudy, Idrus Alwi, Alida R. Harahap, Erlin Listiyaningsih, Lia G. Partakusuma, Arif R. Tansir, Windy Sahar & Rakhmad Hidayat. (2023) The role of clopidogrel resistance-related genetic and epigenetic factors in major adverse cardiovascular events among patients with acute coronary syndrome after percutaneous coronary intervention. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Xibo Ma, Danfeng Li, Shihua Liu, Yan Chen & Ping Zhong. (2023) Efficacy and Safety of Ticagrelor versus Aspirin and Clopidogrel for Stroke Prevention in Patients with Vascular Disease: A Systematic Review and Meta-Analysis. European Neurology 86:4, pages 229-241.
Crossref
Crossref
Iokfai Cheang, Shi Shi, Xinyi Lu, Shengen Liao, Xu Zhu, Xi Su, Qi Lu, Jing Yuan, Dachun Xu, Min Zhang, Cuilian Dai, Jingfeng Wang, Fang Yuan, Yan Zhao, Jingmin Zhou & Xinli Li. (2022) Efficacy and Dosage Pattern of Sacubitril/Valsartan in Chinese Heart Failure with Reduced Ejection Fraction Patients. Journal of Cardiovascular Translational Research 15:5, pages 1192-1202.
Crossref
Crossref
Dae Yong Park, Peter Wang, Seokyung An, Alyssa A. Grimshaw, Jennifer Frampton, E Magnus Ohman, Sunil V. Rao & Michael G. Nanna. (2022) Shortening the duration of dual antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis. American Heart Journal 251, pages 101-114.
Crossref
Crossref
Liye Dai, Jie Xu, Hongyi YanZimo ChenYuesong Pan, Xia MengHao LiYongjun Wang. (2022) Application of Age, Body Mass Index, Chronic Kidney Disease, Diabetes, and Genotyping Score for Efficacy of Clopidogrel: Secondary Analysis of the CHANCE Trial. Stroke 53:2, pages 465-472.
Crossref
Crossref
Ronda Lun, Shan Dhaliwal, Gabriele Zitikyte, Danielle Carole Roy, Brian Hutton & Dar Dowlatshahi. (2022) Comparison of Ticagrelor vs Clopidogrel in Addition to Aspirin in Patients With Minor Ischemic Stroke and Transient Ischemic Attack. JAMA Neurology 79:2, pages 141.
Crossref
Crossref
Hisayuki Hosoo, Eiichi Ishikawa, Wataro Tsuruta, Masayuki Sato, Yoshiro Ito, Mikito Hayakawa, Tomoji Takigawa, Aiki Marushima, Kensuke Suzuki, Akio Hyodo & Yuji Matsumaru. (2022) Antiplatelet Therapy and Periprocedural Risk Factor Analysis for Pipeline Embolization Device Treatment of Unruptured Internal Carotid Artery Aneurysms: A Retrospective, Multicenter Analysis. World Neurosurgery 157, pages e102-e110.
Crossref
Crossref
Byung Gyu Kim, Sung‐Jin Hong, Byeong‐Keuk Kim, Seung‐Jun Lee, Chul‐Min Ahn, Dong‐Ho Shin, Jung‐Sun Kim, Young‐Guk Ko, Donghoon Choi, Myeong‐Ki Hong & Yangsoo Jang. (2021) Age‐Dependent Effect of Ticagrelor Monotherapy Versus Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events: A Post Hoc Analysis of the TICO Randomized Trial. Journal of the American Heart Association 10:24.
Crossref
Crossref
Ning Geng, Li Ren, Lisheng Xu, Deling Zou & Wenyue Pang. (2021) Clinical outcomes of nicorandil administration in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials. BMC Cardiovascular Disorders 21:1.
Crossref
Crossref
Laura M. Willemsen, Eline A. Vlot, Paul W.A. Janssen, Claire D. Visser, Kai Zheng, Johannes C. Kelder, Peter G. Noordzij, Erik‐Jan van den Dool, Patrick Klein, Christian M. Hackeng & Jurrien M. ten Berg. (2021) Blood loss after coronary artery bypass by aspirin responsiveness assessed with preoperative VerifyNow aspirin testing. Research and Practice in Thrombosis and Haemostasis 5:8, pages e12623.
Crossref
Crossref
Sarah Jafrin, Nura Ershad Naznin, Md. Sharif Reza, Md. Abdul Aziz & Mohammad Safiqul Islam. (2021) Risk of stroke in CYP2C19 LoF polymorphism carrier coronary artery disease patients undergoing clopidogrel therapy: An ethnicity-based updated meta-analysis. European Journal of Internal Medicine 90, pages 49-65.
Crossref
Crossref
Rachelle Hollier, Madison Sealy, Nathan Ross & Phillip Ebbs. (2021) Prehospital clopidogrel use and STEMI management: a review. Journal of Paramedic Practice 13:6, pages 1-10.
Crossref
Crossref
Hanxu Zhang, Qian Xiang, Zhiyan Liu, Guangyan Mu, Qiufen Xie, Shuang Zhou, Lingyue Ma, Zining Wang, Kun Hu, Zhe Wang & Yimin Cui. (2020) Genotype‐guided antiplatelet treatment versus conventional therapy: A systematic review and meta‐analysis. British Journal of Clinical Pharmacology 87:5, pages 2199-2215.
Crossref
Crossref
Gabriele Zitikyte, Danielle Carole Roy, Shan Dhaliwal, Ronda Lun, Brian Hutton, Risa Shorr & Dar Dowlatshahi. (2021) Ticagrelor vs Clopidogrel in addition to Aspirin in minor ischemic stroke/ transient ischemic attack—Protocol for a systematic review and network meta-analysis. PLOS ONE 16:4, pages e0250553.
Crossref
Crossref
Mohammed Ahmed Akkaif, Nur Aizati Athirah Daud, Abubakar Sha’aban, Mei Li Ng, Muhamad Ali Sk Abdul Kader, Dzul Azri Mohamed Noor & Baharudin Ibrahim. (2021) The Role of Genetic Polymorphism and Other Factors on Clopidogrel Resistance (CR) in an Asian Population with Coronary Heart Disease (CHD). Molecules 26:7, pages 1987.
Crossref
Crossref
Madison Sealy & Rachelle Hollier. (2021) Appropriateness of oral clopidogrel for prehospital STEMI management. International Paramedic Practice 11:1, pages 4-14.
Crossref
Crossref
Bernadette Boden‐Albala, Salina P. Waddy, Noa Appleton, Heather Kuczynski, Emily Nangle & Nina S. Parikh. 2021. The Science of Health Disparities Research. The Science of Health Disparities Research
413
428
.
Adam Wiśniewski. (2021) Multifactorial Background for a Low Biological Response to Antiplatelet Agents Used in Stroke Prevention. Medicina 57:1, pages 59.
Crossref
Crossref
Adam Wiśniewski & Karolina Filipska. (2020) The Phenomenon of Clopidogrel High On-Treatment Platelet Reactivity in Ischemic Stroke Subjects: A Comprehensive Review. International Journal of Molecular Sciences 21:17, pages 6408.
Crossref
Crossref
Vafa Alakbarzade, Xuya Huang, Irina Chis Ster, Meriel McEntagart & Anthony C. Pereira. (2020) High on-clopidogrel platelet reactivity in ischaemic stroke or transient ischaemic attack: Systematic review and meta-analysis. Journal of Stroke and Cerebrovascular Diseases 29:7, pages 104877.
Crossref
Crossref
Junling DongFajun WangSophia Sundararajan. (2020) Use of Dual Antiplatelet Therapy Following Ischemic Stroke. Stroke 51:5.
Crossref
Crossref
Cheng-An Wang, Yi-Chen Hsieh, Chun-Yao Huang, Ju-Chi Liu, Ming-Hsiung Hsieh, Yung-Kuo Lin & Jong-Shiuan Yeh. (2020) Comparison between ticagrelor versus clopidogrel in long term outcomes of Taiwanese diabetic subjects with acute coronary syndrome undergoing successful revascularization. Medicine 99:19, pages e19969.
Crossref
Crossref
Andrea N. Burnett-Hartman, Erica Blum-Barnett, Nikki M. Carroll, Sarah D. Madrid, Cabell Jonas, Kristen Janes, Monica Alvarado, Ruth Bedoy, Valerie Paolino, Nazneen Aziz & Elizabeth A. McGlynn. (2020) Return of Research-Related Genetic Test Results and Genetic Discrimination Concerns: Facilitators and Barriers of Genetic Research Participation in Diverse Groups. Public Health Genomics 23:1-2, pages 59-68.
Crossref
Crossref
Nabila Akram, Ghulam Mustafa, Anum A Hanif, Shahzad Tawwab, Shabbir Hussain, Haiba Kaul & Shahida Mohsin. (2019)
Cytochrome 2C19
and
paraoxonase-1
polymorphisms and clopidogrel resistance in ischemic heart disease patients
. Personalized Medicine 16:5, pages 379-386.
Crossref
Crossref
Jie Xu, Anxin Wang, Runqi Wangqin, Jinglin Mo, Zimo Chen, Liye Dai, Xia Meng, Xingquan Zhao, Yilong Wang, Hao Li, Wei Chen, Ying Xian & Yongjun Wang. (2019) Efficacy of clopidogrel for stroke depends on CYP2C19 genotype and risk profile. Annals of Neurology 86:3, pages 419-426.
Crossref
Crossref
Dale A. Lauver, Dawn S. Kuszynski, Barbara D. Christian, Matthew P. Bernard, James P. Teuber, Bruce E. Markham, Yuqing E. Chen & Haoming Zhang. (2019)
DT‐678 inhibits platelet activation with lower tendency for bleeding compared to existing P2Y
12
antagonists
. Pharmacology Research & Perspectives 7:4.
Crossref
Crossref
Zhifu Wang, Zhaohui Liu, Wenyao Wang, Yuanyuan Fu, Wen Chen, Wenke Li, Xue Zhang, Yida Tang & Zhou Zhou. (2018) Two common mutations within CYP2C19 affected platelet aggregation in Chinese patients undergoing PCI: a one-year follow-up study. The Pharmacogenomics Journal 19:2, pages 157-163.
Crossref
Crossref
Jong-Won Chung, Suk Jae Kim, Jaechun Hwang, Mi Ji Lee, Jun Lee, Kyung-Yul Lee, Man-Seok Park, Sang Min Sung, Keon Ha Kim, Pyoung Jeon & Oh Young Bang. (2019) Comparison of Clopidogrel and Ticlopidine/Ginkgo Biloba in Patients With Clopidogrel Resistance and Carotid Stenting. Frontiers in Neurology 10.
Crossref
Crossref
Pooja Dewan, Kieran F. Docherty & John J.V. McMurray. (2019) Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction. Korean Circulation Journal 49:6, pages 469.
Crossref
Crossref
Xingyang Yi, Qiang Zhou, Chun Wang, Jing Lin & Zhenxiao Chai. (2018) Aspirin plus clopidogrel may reduce the risk of early neurologic deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles. Journal of Neurology 265:10, pages 2396-2403.
Crossref
Crossref
Jing Lin, Zhao Han, Chun Wang, Xingyang Yi, Zhenxiao Chai, Qiang Zhou & Ruyue Huang. (2018) Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles. European Journal of Clinical Pharmacology 74:9, pages 1131-1140.
Crossref
Crossref
Zaril Zakaria, Alan Fong & Raj Badhan. (2018) Clopidogrel Pharmacokinetics in Malaysian Population Groups: The Impact of Inter-Ethnic Variability. Pharmaceuticals 11:3, pages 74.
Crossref
Crossref
Ning Geng, Deling Zou, Yanli Chen, Li Ren, Lisheng Xu, Wenyue Pang & Yingxian Sun. (2018) Prostaglandin E1 administration for prevention of contrast-induced acute kidney injury. Medicine 97:29, pages e11416.
Crossref
Crossref
Yingying Yang, Mengyuan Zhou, Xi Zhong, Yongjun Wang, Xingquan Zhao, Liping Liu & Yilong Wang. (2018) Dual versus mono antiplatelet therapy for acute non-cardioembolic ischaemic stroke or transient ischaemic attack: a systematic review and meta-analysis. Stroke and Vascular Neurology 3:2, pages 107-116.
Crossref
Crossref
Celina M. Yong, Leo Ungar, Freddy Abnousi, Steven M. Asch & Paul A. Heidenreich. (2018) Racial Differences in Quality of Care and Outcomes After Acute Coronary Syndrome. The American Journal of Cardiology 121:12, pages 1489-1495.
Crossref
Crossref
Yan Wu, Hua Yu, Hai-qin Tang, Yong Su, Tian-lu Shi, Sheng Liu, Quan Xia & Du-juan Xu. (2018) PXR polymorphisms have impact on the clinical efficacy of clopidogrel in patients undergoing percutaneous coronary intervention. Gene 653, pages 22-28.
Crossref
Crossref
Xingyang Yi, Jing Lin, Ju Zhou, Yanfeng Wang, Ruyue Huang & Chun Wang. (2018) The secondary prevention of stroke according to cytochrome P450 2C19 genotype in patients with acute large-artery atherosclerosis stroke. Oncotarget 9:25, pages 17725-17734.
Crossref
Crossref
Y Wang, B P Yan, D Liew & V W Y Lee. (2017) Cost-effectiveness of cytochrome P450 2C19 *2 genotype-guided selection of clopidogrel or ticagrelor in Chinese patients with acute coronary syndrome. The Pharmacogenomics Journal 18:1, pages 113-120.
Crossref
Crossref
Habib Haybar & Zeinab Deris Zayeri. (2017) The value of using polymorphisms in anti-platelet therapy. Frontiers in Biology 12:5, pages 349-356.
Crossref
Crossref
Meor Fairuz Rizal Meor Anuar Shuhaili, Intan Nureslyna Samsudin, Johnson Stanslas, Shariful Hasan & Subashini C. Thambiah. (2017) Effects of Different Types of Statins on Lipid Profile: A Perspective on Asians. International Journal of Endocrinology and Metabolism In Press:In Press.
Crossref
Crossref
Chen-Yu Wang, Zhen-Fang Lin, Chii-Ming Lee, Yi-Wen Tsai, Ting-Ying Huang, Li-Jiuan Shen & Fei-Yuan Hsiao. (2017) Concomitant use of calcium channel blockers with dual antiplatelet therapy and re-hospitalization for acute coronary syndrome. Pharmacoepidemiology and Drug Safety 26:3, pages 229-238.
Crossref
Crossref
Pengxin GeLi DuChunguang HanHui LiYanguo FengJie Han, Zhen WangLiangzhong XiongMeiru YuanYongxue Liu. (2017) W1, a Novel Oral Antiplatelet Agent With Less Resistance Than Clopidogrel. Journal of Cardiovascular Pharmacology 69:2, pages 110-117.
Crossref
Crossref
Yuesong PanWeiqi ChenYun XuXingyang YiYan HanQingwu YangXin LiLi’an HuangS. Claiborne JohnstonXingquan ZhaoLiping LiuQi ZhangGuangyao WangYongjun WangYilong Wang. (2017) Genetic Polymorphisms and Clopidogrel Efficacy for Acute Ischemic Stroke or Transient Ischemic Attack. Circulation 135:1, pages 21-33.
Crossref
Crossref
Li-Jun Zhang, Yan-Qun Zhang, Xia Han, Zeng-Tang Zhang & Zhi-Qiang Zhang. (2016) Association of VEGFR-2 Gene Polymorphisms With Clopidogrel Resistance in Patients With Coronary Heart Disease. American Journal of Therapeutics 23:6, pages e1663-e1670.
Crossref
Crossref
Min Soo Kim, Kyung Il Jo, Je Young Yeon, Jong Soo Kim, Keon Ha Kim, Pyoung Jeon & Seung Chyul Hong. (2016) Safety and efficacy of antiplatelet response assay and drug adjustment in coil embolization: a propensity score analysis. Neuroradiology 58:11, pages 1125-1134.
Crossref
Crossref
H. Zhang, D. A. Lauver, H. Wang, D. Sun, P. F. Hollenberg, Y. E. Chen, Y. Osawa & D. T. Eitzman. (2016) Significant Improvement of Antithrombotic Responses to Clopidogrel by Use of a Novel Conjugate as Revealed in an Arterial Model of Thrombosis. Journal of Pharmacology and Experimental Therapeutics 359:1, pages 11-17.
Crossref
Crossref
Pan Li, Ying Gu, Yawei Yang, Lizhi Chen, Junmei Liu, Lihong Gao, Yongwen Qin, Quancai Cai, Xianxian Zhao, Zhuo Wang & Liping Ma. (2016) Low-dose ticagrelor yields an antiplatelet efficacy similar to that of standard-dose ticagrelor in healthy subjects: an open-label randomized controlled trial. Scientific Reports 6:1.
Crossref
Crossref
Rui Liu, Zi-yi Zhou, Yi-bei Chen, Jia-li Li, Wei-bang Yu, Xin-meng Chen, Min Zhao, Yuan-qi Zhao, Ye-feng Cai, Jing Jin & Min Huang. (2016) Associations of CYP3A4, NR1I2, CYP2C19 and P2RY12 polymorphisms with clopidogrel resistance in Chinese patients with ischemic stroke. Acta Pharmacologica Sinica 37:7, pages 882-888.
Crossref
Crossref
Sam S. Oh, Marquitta J. White, Christopher R. Gignoux & Esteban G. Burchard. (2016) Making Precision Medicine Socially Precise. Take a Deep Breath. American Journal of Respiratory and Critical Care Medicine 193:4, pages 348-350.
Crossref
Crossref
Hua Shao, Jia Lu, Yun-Ting Xu, Ying Zhan, Guo-Ming Chen & Hong-Jian Zhang. (2016) Metabolic Interaction Potential between Clopidogrel and Sulfonylurea Antidiabetic Agents: Effects on Clopidogrel Bioactivation. Pharmacology 97:1-2, pages 18-24.
Crossref
Crossref
Mark Y. Chan, Xin Du, David Eccleston, Changsheng Ma, Padinhare P. Mohanan, Manabu Ogita, Kou-Gi Shyu, Bryan P. Yan & Young-Hoon Jeong. (2016) Acute coronary syndrome in the Asia-Pacific region. International Journal of Cardiology 202, pages 861-869.
Crossref
Crossref
Xi-Ling Jiang, Snehal Samant, Joshua P. Lewis, Richard B. Horenstein, Alan R. Shuldiner, Laura M. Yerges-Armstrong, Lambertus A. Peletier, Lawrence J. Lesko & Stephan Schmidt. (2016) Development of a physiology-directed population pharmacokinetic and pharmacodynamic model for characterizing the impact of genetic and demographic factors on clopidogrel response in healthy adults. European Journal of Pharmaceutical Sciences 82, pages 64-78.
Crossref
Crossref
Khalid Bin Thani, Fajer Al-Moosa, Eman Murad, Aisha Al-Moosa, Mohamed E. Alalawi & Hind Al-Sindi. (2015) Stent Thrombosis after Rescue Percutaneous Coronary Intervention in
Acute ST-Segment Elevation Myocardial Infarction. The Open Cardiovascular Medicine Journal 9:1, pages 127-132.
Crossref
Crossref
Emad Ahmed & Ayman El-Menyar. (2014) South Asian Ethnicity and Cardiovascular Risk. Angiology 66:5, pages 405-415.
Crossref
Crossref
Xi-Ling Jiang, Snehal Samant, Lawrence J. Lesko & Stephan Schmidt. (2015) Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel. Clinical Pharmacokinetics 54:2, pages 147-166.
Crossref
Crossref
Shijun Zhang, Xinqiang Lai, Wenxian Li, Zhen Jing, Zhilin Xiong, Anding Xu, Yiwen Ruan & Li'an Huang. (2014) VASP phosphorylation and genetic polymorphism for clopidogrel resistance in Chinese patients with non-cardioembolic ischemic stroke. Thrombosis Research 134:6, pages 1272-1277.
Crossref
Crossref
Anene Ukaigwe, Paras Karmacharya, Maryam Mahmood, Ranjan Pathak, Madan Raj Aryal, Leena Jalota & Anthony A. Donato. (2014) Meta-Analysis on Efficacy of Statins for Prevention of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography. The American Journal of Cardiology 114:9, pages 1295-1302.
Crossref
Crossref
Y. Hiasa, R. Teng & H. Emanuelsson. (2014) Pharmacodynamics, pharmacokinetics and safety of ticagrelor in Asian patients with stable coronary artery disease. Cardiovascular Intervention and Therapeutics 29:4, pages 324-333.
Crossref
Crossref
Charles V. PollackJr.Jr., Alpesh Amin, Tomas Villanueva, Frank Peacock, Richard Summers, George Davatelis & Scott Kaatz. (2014) Rationale for Upstream Dual Antiplatelet Therapy in Non-ST-Segment Elevation Myocardial Infarction. Current Emergency and Hospital Medicine Reports 2:1, pages 76-89.
Crossref
Crossref
Hong-Guang Xie & Ying-Dong Zhang. 2013. Omics for Personalized Medicine. Omics for Personalized Medicine
469
506
.